Clinical trial Recruiting at 1 site Phase1; Phase2 Interventional Ages 40 to 75

Injections of stem cells for treating knee osteoarthritis

Official title: Allogenic Mesenchymal Stem Cell Intraarticular Injection for Knee Osteoarthritis Therapy, an RCT Explorative Mode-of-action Study

Run by Aarhus University Hospital · NCT05933434 · Data updated 2026-11-12

This study is testing if injections of stem cells can help people with mild to moderate knee osteoarthritis feel less pain and move better compared to a placebo injection.

More Knee Osteoarthritis trials

Quick facts

PhasePhase1; Phase2
Study typeInterventional
Ages40 Years to 75 Years
SexAll
Enrollment80 (estimated)
SponsorAarhus University Hospital
Academic / other
Locations1 site (Aarhus N)
StatusRecruiting
StartedMarch 7, 2024
Main results expectedOctober 2030
Study endsOctober 2030
Registry record updatedJune 11, 2024
Trial IDNCT05933434 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are Danish-speaking adults with chronic knee pain and Grade II-III osteoarthritis.

Probably not a fit

Patients with severe osteoarthritis or those who have had recent knee injections or surgeries may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the safety and effectiveness of injecting allogenic adipose-derived mesenchymal stem cells (AD-MSC) into the knee joint of patients with mild to moderate knee osteoarthritis. Participants will be randomly assigned to receive either the stem cell injection or a placebo saline injection. The study aims to determine if the stem cell treatment can alleviate chronic knee pain and improve joint function compared to the placebo. It is a double-blinded trial, ensuring that neither the participants nor the researchers know who receives which treatment.

Why it matters

Potential benefit: If successful, this treatment could provide a new, effective option for patients suffering from knee osteoarthritis, potentially reducing pain and improving mobility.

How similar studies have gone: Previous studies have shown promise in using stem cells for joint therapy, but this specific approach is still being evaluated for its efficacy.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Chronic knee pain (defined for at least 6 months with NRS 4 or above when pain worst)
* Patients with Grade II-III osteoarthritis according to the Kellgren Lawrence Classification and a joint width space of 1-3 mm.
* Axial hip, knee, ankle x-ray with no more than 5 degrees valgus/varus deformity
* Medial, lateral or dual compartment OA as determined above
* BMI \<35
* Danish speaker
* Patients must be legally competent and must be able to sign the written consent

Exclusion Criteria:

* Severe Osteoarthritis (Grade IV according to Kellgren Lavrence Classification)
* Intraarticular tumor, infection or fracture
* Pregnancy and breast feeding
* Cognitive impairment
* Treatment with cytostatic drugs
* Previous intraarticular knee injection in the past 3 mo.
* Unable to perform MRI scan (non-compatible implants, claustrophobia and severe obesity(\>BMI 35)
* Previous ligament reconstruction
* Meniscal operation with resection with more than 50% or multiple meniscal operations (more than one resection)
* Diabetes mellitus type 1 and 2
* Knee instability on physical examination
* History of allergy to antibiotics
* Concomitant severe infection, malignant tumor, coagulation diseases or uncontrolled or unmanaged systemic disease
* Presence of other types of inflammatory arthritis

Where it's running

  • Aarhus University
    Aarhus N, Denmark
    Recruiting

Study contacts

  • Principal investigator: Rasmus Aabling, MD — University of Aarhus
  • Study coordinator: Rasmus Aabling, MD
  • Email: rasaab@clin.au.dk
  • Phone: +4528496767

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.